Disease/Condition Addressed (PI1533)

Describes the diseases or conditions addressed by the organization's products or services provided during the reporting period. Select all that apply:

  • 01 Certain infectious or parasitic diseases
  • 02 Neoplasms
  • 03 Diseases of the blood or blood-forming organs
  • 04 Diseases of the immune system
  • 05 Endocrine, nutritional, or metabolic diseases
  • 06 Mental, behavioural or neurodevelopmental disorders
  • 07 Sleep-wake disorders
  • 08 Diseases of the nervous system
  • 09 Diseases of the visual system
  • 10 Diseases of the ear or mastoid process
  • 11 Diseases of the circulatory system
  • 12 Diseases of the respiratory system
  • 13 Diseases of the digestive system
  • 14 Diseases of the skin
  • 15 Diseases of the musculoskeletal system or connective tissue
  • 16 Diseases of the genitourinary system
  • 17 Conditions related to sexual health
  • 18 Pregnancy, childbirth, or the puerperium
  • 19 Certain conditions originating in the perinatal period
  • 20 Developmental anomalies
  • 21 Symptoms, signs or clinical findings, not elsewhere classified
  • 22 Injury, poisoning or certain other consequences of external causes
  • 23 External causes of morbidity or mortality
  • 24 Factors influencing health status or contact with health services
  • 25 Codes for special purposes
  • 26 Supplementary Chapter Traditional Medicine Conditions - Module I
  • Reporting Format Selection
  • Metric Type Metric
  • Metric Level Product/Service, Organization
  • IRIS Metric Citation IRIS, 2021. Disease/Condition Addressed (PI1533). v5.2.
Footnote

Organizations should footnote details about how their products and services address the selected diseases or conditions. See usage guidance for further information.